Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | LPE(20:4) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 80.7 | pmol/sample |
| - | LPE(20:4) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 158 | pmol/sample |
| - | LPE(20:4) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 123 | pmol/sample |
| - | LPE(20:4) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 392 | pmol/sample |
| - | LPE(20:4) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 518 | pmol/sample |
| - | LPE(20:4) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 564 | pmol/sample |
| - | LPE(20:4) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 153 | pmol/sample |
| - | LPE(20:4) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 246 | pmol/sample |
| - | LPE(20:4) | C | 0.0 | BCD100322A01 | 199 | pmol/sample |
| - | LPE(20:4) | C | 0.5 | BCD100322A03 | 153 | pmol/sample |
| - | LPE(20:4) | C | 1.0 | BCD100322A07 | 156 | pmol/sample |
| - | LPE(20:4) | C | 2.0 | BCD100322A11 | 151 | pmol/sample |
| - | LPE(20:4) | C | 4.0 | BCD100322A15 | 326 | pmol/sample |
| - | LPE(20:4) | C | 8.0 | BCD100322A19 | 578 | pmol/sample |
| - | LPE(20:4) | C | 12.0 | BCD100322A23 | 628 | pmol/sample |
| - | LPE(20:4) | C | 24.0 | BCD100322A27 | 257 | pmol/sample |
| - | LPE(20:4) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 131 | pmol/sample |
| - | LPE(20:4) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 161 | pmol/sample |
| - | LPE(20:4) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 309 | pmol/sample |
| - | LPE(20:4) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 431 | pmol/sample |
| - | LPE(20:4) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 558 | pmol/sample |
| - | LPE(20:4) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 215 | pmol/sample |
| - | LPE(20:4) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 175 | pmol/sample |
| - | LPE(20:4) | 25OH-Chol | 0.5 | BCD100322A04 | 161 | pmol/sample |
| - | LPE(20:4) | 25OH-Chol | 1.0 | BCD100322A08 | 179 | pmol/sample |
| - | LPE(20:4) | 25OH-Chol | 2.0 | BCD100322A12 | 206 | pmol/sample |
| - | LPE(20:4) | 25OH-Chol | 4.0 | BCD100322A16 | 468 | pmol/sample |
| - | LPE(20:4) | 25OH-Chol | 8.0 | BCD100322A20 | 726 | pmol/sample |
| - | LPE(20:4) | 25OH-Chol | 12.0 | BCD100322A24 | 538 | pmol/sample |
| - | LPE(20:4) | 25OH-Chol | 24.0 | BCD100322A28 | 244 | pmol/sample |